公开(公告)号：US20230321127A1

公开(公告)日：2023-10-12

申请号：US18044089

申请日：2021-09-07

Applicant: MIRAILAB BIOSCIENCE INC. ,  HIROSHIMA UNIVERSITY

Inventor： Megumi TANAKA ,  Tsunemaru TANAKA ,  Masayuki SHIMADA

IPC: A61K31/706 ,  A61K31/4745 ,  A61P15/08

CPC classification number: A61K31/706 ,  A61K31/4745 ,  A61P15/08

Abstract: [PROBLEM] To provide a sperm motility improvement agent that is highly safe and may effectively improve sperm motility.
[SOLUTION] A sperm motility improvement agent comprising nicotinamide mononucleotide as an active ingredient.

公开(公告)号：US20230416291A1

公开(公告)日：2023-12-28

申请号：US18038351

申请日：2021-11-26

Applicant: MIRAILAB BIOSCIENCE INC.

Inventor： Tsunemaru TANAKA ,  Megumi TANAKA ,  Ryuji HIRAMATSU ,  Daizo SHIMAMURA

IPC: C07H19/048 ,  C07H1/06 ,  C12P19/30

CPC classification number: C07H19/048 ,  C07H1/06 ,  C12P19/30

Abstract: The present invention addresses the problem of a providing NMN having high purity and a low impurity content. The present invention is a high-purity β-nicotinamide mononucleotide (NMN) which has a purity of 99.0 mass % or higher and in which the amounts of C11H15NO9P, C10H16N5O10P2, C9H15N3O8P, C9H15N3O7P, C9H16N4O8P, C10H15N5O7P, and C21H27N6O15P2 contained as impurities are equal to or less than a detection limit.

公开(公告)号：US20240350525A1

公开(公告)日：2024-10-24

申请号：US18689437

申请日：2022-09-05

Applicant: MIRAILAB BIOSCIENCE INC.

Inventor： Megumi TANAKA ,  Tsunemaru TANAKA

IPC: A61K31/706 ,  A61P9/06

CPC classification number: A61K31/706 ,  A61P9/06

Abstract: [PROBLEM] To provide a medicine for heart disease that is safe for use over a long period of time and useful for effectively improving heart diseases.
[SOLUTION] The present invention is a medicine for heart disease containing nicotinamide mononucleotide as an active ingredient.